Skip to main content
Home
User account menu
  • IRBManager
  • CTSU
Main navigation
  • Home
  • About
    • Our Mission
    • Our History
    • Who’s Involved
    • About the Boards
      • Adult CIRB - Late Phase Emphasis Members
      • Adult CIRB - Early Phase
      • Pediatric CIRB
      • Cancer Prevention and Control CIRB
    • CIRB SOPs
    • List of Institutions
    • Studies
  • For New Users
    • Overview of the Study Review Process
    • Frequently Asked Questions about Navigating IRBManager
    • When To Use NCI CIRB, IRBManager, and CTSU Websites
  • For Institutions
    • IRBManager Basics
    • Overview of the Study Review Process
    • Becoming A Signatory Institution
    • Navigating The CIRB For NCI Division of Cancer Prevention (DCP) Consortia Sites And Cancer Prevention Clinical Trial Network (CP-CTNET) Organizations
    • Create and Update the Signatory Institution Worksheet
      • Completing The Annual Signatory Institution Worksheet
      • Establishing Your Signatory Institution
      • Short Form Q & A
    • Creating and Updating the Annual Principal Investigator Worksheet
      • Establishing a Principal Investigator
    • How to Open a Study
      • Opening a Study
    • Change the PI on a Study
      • Changing the PI on a Study
    • Submit a Study Closure
    • Report A Potential Unanticipated Problem Or A Serious Or Continuing Noncompliance
    • Request an Assent Waiver
      • Completing The Assent Waiver Worksheet
    • Notify the CIRB about the participation of an incarcerated participant
      • Completing The Notification of Incarcerated Participant Worksheet
      • Institution Q & A
      • Boilerplate Language Q & A
      • Finding Information Q & A
      • Guidelines For Permitted Boilerplate Language Additions
      • Individual Roles Within The CIRB
      • Institutions' Roles With The CIRB
      • Managing Your CTEP Registration
      • Oversight Q & A
      • Updating Your CIRB Institution Roster using RUMS
      • Updating Your CIRB Person Roster using RUMS
      • Viewing Your CIRB Roster
  • For Networks
    • Overview of the Study Review Process
    • CIRB Document Posting
    • Submitting Studies
      • Completing The Translation Application
      • Completing The Unanticipated Problem And/Or Serious or Continuing Noncompliance Submission Application
      • Completing The Waiver Of Consent Application
      • Determining Waiver Of Consent Requirements
      • End User Licensing Agreement (Eula) Consent Form Language Q & A
      • Review of Translated Consent Forms, PROs, and Other Patient-Facing Documents
      • Submitting Recruitment/participant Materials For Review
    • CIRB Meeting Schedules
  • For Board Members
    • Become A Board Member
    • Overview of the Study Review Process
    • Resources
      • Helpful URLs
      • IRBManager Training for Board Members
    • CIRB Meeting Schedules
  • Contact Us

EA2174

  • Read more about EA2174

EAA172

  • Read more about EAA172

10212

  • Read more about 10212

10181

  • Read more about 10181

10214

  • Read more about 10214

10195

  • Read more about 10195

10204

  • Read more about 10204

10208

  • Read more about 10208

10246

  • Read more about 10246

10247

  • Read more about 10247

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 148
  • Page 149
  • Page 150
  • Page 151
  • Current page 152
  • Page 153
  • Page 154
  • Page 155
  • Page 156
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to
Close

The NCI Central Institutional Review Board

401 N. Washington Street, Ste. 700
Rockville, MD 20850

The Central Institutional Review Board for the National Cancer of Institute is fully accredited by the Association for the Accreditation of Human Research Protection Program, Inc.